Parental longevity and diabetes risk in the diabetes prevention program

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 66 A, Issue 11, 2011, Pages 1211-1217

  Florez, Hermes ^a   Ma, Yong ^b   Crandall, Jill P ^c   Perreault, Leigh ^d   Marcovina, Santica M ^e   Bray, George A ^f   Saudek, Christopher D ^g   Barrett Connor, Elizabeth ^h   Knowler, William C ⁱ  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Diabetes Prevention Program; Diabetes risk; Parental longevity

Indexed keywords

ADULT; ADULT CHILD; ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FAMILY HEALTH; FEMALE; HUMAN; LONGEVITY; LONGITUDINAL STUDY; MALE; PARENT; PHYSIOLOGY; RISK FACTOR;

ADULT; ADULT CHILDREN; CORONARY DISEASE; DIABETES MELLITUS; FAMILY HEALTH; FEMALE; HUMANS; LONGEVITY; LONGITUDINAL STUDIES; MALE; PARENTS; RISK FACTORS;

EID: 80054878618     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr114     Document Type: Article

References (58)

1. Gallucci M, Ongaro F, Bresolin F, et al. The Treviso Longeva (Trelong) study: a biomedical, demographic, economic and social investigation on people 70 years and over in a typical town of North-East of Italy. Arch Gerontol Geriatr. 2007;44(suppl 1):173-192. (Pubitemid 46273720)
2. Dupre ME, Liu G, Gu D. Predictors of longevity: evidence from the oldest old in China. Am J Public Health. 2008;98:1203-1208. (Pubitemid 351947991)
3. Perls TT, Wilmoth J, Levenson R, et al. Lifelong sustained mortality advantage of siblings of centenarians. Proc Natl Acad Sci USA. 2002;99:8442-8447. (Pubitemid 34651071)
4. Atzmon G, Schechter C, Greiner W, et al. Clinical phenotype of families with longevity. J Am Geriatr Soc. 2004;52:274-277. (Pubitemid 38233493)
5. Christensen K, Johnson TE, Vaupel JW. The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet. 2006;7:436-448. (Pubitemid 43780487)
6. Chung W-H, Dao RL, Chen LK, Hung SI. The role of genetic variants in human longevity. Aging Res Rev. 2010;9(suppl 1):S67-S78.
7. Vandenbroucke JP, Matroos AW, van der Heide-Wessel C, et al. Parental survival, an independent predictor of longevity in middle-aged persons. Am J Epidemiol. 1984;119:742-750. (Pubitemid 14142812)
8. Petersen L, Nielsen GG, Andersen PK, Sørensen TI. Case-control study of genetic and environmental influences on premature death of adult adoptees. Genet Epidemiol. 2002;23:123-132. (Pubitemid 34982040)
9. Ikeda A, Iso H, Toyoshima H, et al. Parental longevity and mortality amongst Japanese men and women: the JACC Study. J Intern Med. 2006;259:285-295.
10. Perls T, Kohler IV, Andersen S, et al. Survival of parents and siblings of supercentenarians. J Gerontol A Biol Sci Med Sci. 2007;62:1028-1034. (Pubitemid 47531221)
11. Terry DF, Wilcox MA, McCormick MA, Perls TT. Cardiovascular disease delay in centenarian offspring. J Gerontol. 2004;59A:385-389. (Pubitemid 38478738)
12. Zureik M, Galan P, Bertrais S, et al. Parental longevity and 7-year changes in blood pressures in adult offspring. Hypertension. 2005;46:287-294. (Pubitemid 41099159)
13. Zureik M, Czernichow S, Courbon D, et al. Parental longevity, carotid atherosclerosis, and aortic arterial stiffness in adult offspring. Stroke. 2006;37:2702-2707. (Pubitemid 44922529)
14. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434-444. (Pubitemid 23046633)
15. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care. 1998;21:1167-1172. (Pubitemid 28368527)
16. Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. 1999;282:1547-1553. (Pubitemid 29504048)
17. Khaw KT, Wareham N, Bingham S, et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141:413-420.
18. Kramarow E, Lubitz J, Lentzner H, Gorina Y. Trends in the health of older Americans, 1970-2005. Health Aff. 2007;26:1417-1425.
19. Diabetes Prevention Program Research Group; Knowler WC, Barrett-Connor E, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. (Pubitemid 34437694)
20. Diabetes Prevention Program Research Group; Crandall J, Schade D, et al. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci. 2006;61:1075-1081. (Pubitemid 44727217)
21. Diabetes Prevention Program Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25:2165-2171.
22. Budovsky A, Muradian KK, Fraifeld VE. From disease-oriented to aging/longevity-oriented studies. Rejuvenation Res. 2006;9:207-210. (Pubitemid 43856809)
23. Kaati G, Bygren LO, Pembrey M, Sjöström M. Transgenerational response to nutrition, early life circumstances and longevity. Eur J Hum Genetics. 2007;15:784-790. (Pubitemid 46965412)
24. Diabetes Prevention Program Research Group. The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999;22:623-634.
25. Fujimoto WY; Diabetes Prevention Program Research Group. Background and recruitment data for the U.S. Diabetes Prevention Program. Diabetes Care. 2000;23(suppl 2):B11-B13. (Pubitemid 30185772)
26. The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. Diabetes Care. 2000;23:1619-1629.
27. Phillips DI, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med. 1994;11:286-292. (Pubitemid 24144145)
28. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. (Pubitemid 15018832)
29. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report on the Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
30. Alberti K, Zimmet P, for the WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diab Med. 1998;15:539-553. (Pubitemid 28319935)
31. Sørensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 1988;318:727-732. (Pubitemid 18090256)
32. Little RJ, Rubin DB. Statistical Analysis with Missing Data, 2nd ed. New York: John Wiley & Sons; 2002.
33. Lehmann EL. Nonparametric Statistical Methods Based on Ranks; New York: McGraw-Hill; 1975.
34. Cox DR. Regression models and life tables. J R Stat Soc Series B. 1972;34:187-220.
35. Crandall JP, Knowler WC, Kahn SE, et al. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab. 2008;4:382-393. (Pubitemid 351881862)
36. Frederiksen H, McGue M, Jeune B, et al. Do children of long-lived parents age more successfully? Epidemiology. 2002;13:334-339. (Pubitemid 34415855)
37. Rozing MP, Westendorp RG, de Craen AJ, et al. Favorable glucose tolerance and lower prevalence of metabolic syndrome in offspring without diabetes mellitus of nonagenarian siblings: the Leiden longevity study. J Am Geriatr Soc. 2010;58:564-569.
38. Westendorp RG, van Heemst D, Rozing MP, et al. Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: the Leiden Longevity Study. J Am Geriatr Soc. 2009;57:1634-1637.
39. Heijmans BT, Beekman M, Houwing-Duistermaat JJ, et al. Lipoprotein particle profiles mark familial and sporadic human longevity. PLoS Med. 2006;3:e495.
40. Lipton RB, Hirsch J, Katz MJ, et al. Exceptional parental longevity associated with lower risk of Alzheimer's disease and memory decline. J Am Geriatr Soc. 2010;58:1043-1049.
41. Gjonça E, Zaninotto P. Blame the parents? The association between parental longevity and successful ageing. Demogr Res. 2008;19:1435-1450.
42. Yarnell J, Yu S, Patterson C, et al. Family history, longevity, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol. 2003;32:71-77. (Pubitemid 36503478)
43. Capri M, Salvioli S, Sevini F, et al. The genetics of human longevity. Ann N Y Acad Sci. 2006;1067:252-263. (Pubitemid 43810006)
44. Cluett C, Melzer D. Human genetic variations: beacons on the pathways to successful ageing. Mech Ageing Dev. 2009;130:553-563.
45. Salvioli S, Olivieri F, Marchegiani F, et al. Genes, ageing and longevity in humans: problems, advantages and perspectives. Free Radic Res. 2006;40:1303-1323. (Pubitemid 44698280)
46. Eggertsen G, Tegelman R, Ericsson S, et al. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem. 1993;39:2125-2129. (Pubitemid 23306162)
47. Schächter F, Faure-Delanef L, Guénot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6:29-32. (Pubitemid 24191909)
48. Jazwinski SM, Kim S, Dai J, et al. HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging. Aging Cell. 2010;9:698-708.
49. Willcox BJ, Donlon TA, He Q, et al. FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci USA. 2008;105:13987-13992.
50. Anselmi CV, Malovini A, Roncarati R, et al. Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res. 2009;12:95-104.
51. Flachsbart F, Caliebe A, Kleindorp R, et al. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc Natl Acad Sci USA. 2009;106:2700-2705.
52. Pawlikowska L, Hu D, Huntsman S, et al. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell. 2009;8:460-472.
53. Lunetta KL, D'Agostino RB Sr, Karasik D, et al. Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study. BMC Med Genes. 2007;8(suppl 1):S13.
54. Flachsbart F, Franke A, Kleindorp R, et al. Investigation of genetic susceptibility factors for human longevity-a targeted nonsynonymous SNP study. Mutat Res. 2010;694:13-19.
55. Majithia AR, Florez JC. Clinical translation of genetic predictors for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2009;16:100-106.
56. Petrie JR, Pearson ER, Sutherland C. Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology. Biochem Pharmacol. 2011;81:471-477.
57. Mooijaart SP, van Heemst D, Noordam R, et al. Polymorphisms associated with type 2 diabetes in familial longevity: the Leiden Longevity Study. Aging. 2011;3:55-62.
58. Zeng Y, Cheng L, Chen H, et al. Effects of FOXO genotypes on longevity: a biodemographic analysis. J Gerontol A Biol Sci Med Sci. 2010;65:1285-1299.